Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2025-12-25 @ 12:04 AM
NCT ID:
NCT02186158
Eligibility Criteria:
Inclusion Criteria:
* people aged ≥ 75 years old
* pneumonia's symptoms according to the SPILF (Société de Pathologie Infectieuse de Langue Française) :
* cough
* at least one respiratory sign : dyspnea, chest pain, wheezing, and local signs at the auscultation
* at least one general sign suggesting an infection : fever, sweat, headache, sore joints, common cold
* pneumonia's symptoms developed between the admission's date in the unit care and the seventh day included
Exclusion Criteria:
* palliative care's patients
* patients with deglutition's disorders
* patients who can't be on a drip
* antibiotherapy since more one day
* other concomitant infection(s)
* patients who can't make their own transfer 15 days ago
* patients who have a NYHA score at IV 15 days ago
* patients with contraindication to a vitamin C treatment : hemochromatosis, oxalo-calcic lithiasis antecedent, G6PD deficit (Glucose 6 Phosphate Dehydrogenase), and treatment by Deferoxamine
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
75 Years
Study:
NCT02186158
Study Brief:
Protocol Section:
NCT02186158